Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension

This publication has 22 references indexed in Scilit:

• Monotherapy of Hypertension with Angiotensin-Converting Enzyme Inhibitors
  The American Journal of Medicine, 1984
• Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor
  The American Journal of Cardiology, 1984
• Enalapril maleate and a lysine analogue (MK‐521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
  British Journal of Clinical Pharmacology, 1982
• Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.
  British Journal of Clinical Pharmacology, 1982
• Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
  British Journal of Clinical Pharmacology, 1981
• Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation
  The American Journal of Medicine, 1980
• Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension.
  Circulation, 1978
• Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine
  Life Sciences, 1977
• Pathophysiologic assessment of hypertensive heart disease with echocardiography
  The American Journal of Cardiology, 1977
• Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy
  The American Journal of Cardiology, 1976